Figure 5.The three-gene signature was associated with prognosis in patients with metastatic lymph nodes. Kaplan-Meier analysis of the OS of patients with metastatic lymph nodes in discovery cohort (A), validation-1 cohort (B) and validation-2 cohort (C). (D) Kaplan-Meier analysis was performed by combining of above three cohorts.
